The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of poziotinib in patients with EGFR or HER2 exon 20 mutation-positive non-small cell lung cancer.
 
Zandong Yang
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Nishan Tchekmedyian
Stock and Other Ownership Interests - Biomarin (I); Exelixis (I); global therapeutics (I); Halozyme (I); Infinity Pharmaceuticals (I); Portola Pharmaceuticals; Trillium Therapeutics (I)
Consulting or Advisory Role - IntrinsiQ; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - IntrinsiQ
 
David T. Chu
Research Funding - Spectrum Pharmaceuticals
 
Guru Reddy
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Gajanan Bhat
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Mark A. Socinski
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Genentech; Pfizer (Inst)